This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rigrodsky & Long, P.A. Announces An Investigation Of ZELTIQ Aesthetics, Inc. For Possible Violations Of The Federal Securities Laws

Rigrodsky & Long, P.A. announces that it has commenced an investigation of ZELTIQ Aesthetics, Inc. (“ZELTIQ” or the “Company”) (NASDAQ: ZLTQ) on behalf of all purchasers of the securities of the Company’s common stock between October 24, 2011 and March 5, 2012, inclusive (the “Relevant Period”), for possible violations of the federal securities laws by the Company and certain of its officers.

ZELTIQ, a Delaware corporation based in Pleasanton, California, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, primarily its proprietary controlled-cooling technology platform, “CoolSculpting.” ZELTIQ engaged in an initial public offering in October 2011 in which the Company raised $89.3 million. Rigrodsky & Long, P.A. is investigating allegations that throughout the Relevant Period, certain officers of the company issued materially false and misleading statements concerning delayed sales at ZELTIQ and failed to disclose adverse information concerning increased competition.

On March 6, 2012, ZELTIQ announced fourth quarter 2011 sales and profits substantially below analysts’ estimates, reporting a loss of $0.22 per share. The Company also estimated 2012 sales of approximately $90 million to $94 million, significantly below analysts’ estimates of $114 million. On this news, the price of ZELTIQ’s common stock fell approximately 47%, from a close of $11.11 per share on March 5, 2012 to close at $5.56 per share on March 8, 2012.

If you purchased ZELTIQ common stock during the Relevant Period and wish to discuss this investigation, or have any questions concerning this notice or your rights or interests, please contact Timothy J. MacFall, Esquire or Scott J. Farrell, Esquire of Rigrodsky & Long, P.A., 825 East Gate Boulevard, Suite 300, Garden City, NY at (888) 969-4242, by e-mail to info@rigrodskylong.com, or at: http://www.rigrodskylong.com/investigations/zeltiq-aesthetics-inc-zltq.

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly litigates securities class, derivative and direct actions, shareholder rights litigation and corporate governance litigation, including claims for breach of fiduciary duty and proxy violations in the Delaware Court of Chancery and in state and federal courts throughout the United States.

Attorney advertising. Prior results do not guarantee a similar outcome.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs